1Life Healthcare, Inc.
1Life Healthcare, Inc. ONEM Peers
See (ONEM) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ONEM | $16.47 | N/A | 3.4B | -7.77 | -$2.12 | N/A |
| VEEV | $284.79 | +2.21% | 46.4B | 60.59 | $4.70 | N/A |
| GEHC | $71.14 | +1.41% | 32.6B | 14.95 | $4.76 | +0.18% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | +0.18% |
| DOCS | $53.51 | +3.89% | 10B | 48.20 | $1.11 | N/A |
| HQY | $103.71 | +0.88% | 9B | 95.15 | $1.09 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| BTSG | $23.67 | -1.09% | 4.1B | 87.67 | $0.27 | N/A |
| BTSGU | $82.54 | -1.33% | 4.1B | N/A | N/A | N/A |
Stock Comparison
ONEM vs VEEV Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, VEEV has a market cap of 46.4B. Regarding current trading prices, ONEM is priced at $16.47, while VEEV trades at $284.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas VEEV's P/E ratio is 60.59. In terms of profitability, ONEM's ROE is -0.24%, compared to VEEV's ROE of +0.14%. Regarding short-term risk, ONEM is more volatile compared to VEEV. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs GEHC Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, GEHC has a market cap of 32.6B. Regarding current trading prices, ONEM is priced at $16.47, while GEHC trades at $71.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas GEHC's P/E ratio is 14.95. In terms of profitability, ONEM's ROE is -0.24%, compared to GEHC's ROE of +0.26%. Regarding short-term risk, ONEM is more volatile compared to GEHC. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs GEHCV Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, ONEM is priced at $16.47, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas GEHCV's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to GEHCV's ROE of +0.26%. Regarding short-term risk, ONEM is less volatile compared to GEHCV. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs DOCS Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, DOCS has a market cap of 10B. Regarding current trading prices, ONEM is priced at $16.47, while DOCS trades at $53.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas DOCS's P/E ratio is 48.20. In terms of profitability, ONEM's ROE is -0.24%, compared to DOCS's ROE of +0.22%. Regarding short-term risk, ONEM is less volatile compared to DOCS. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs HQY Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, HQY has a market cap of 9B. Regarding current trading prices, ONEM is priced at $16.47, while HQY trades at $103.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas HQY's P/E ratio is 95.15. In terms of profitability, ONEM's ROE is -0.24%, compared to HQY's ROE of +0.05%. Regarding short-term risk, ONEM is more volatile compared to HQY. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs SGFY Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, ONEM is priced at $16.47, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SGFY's P/E ratio is 70.91. In terms of profitability, ONEM's ROE is -0.24%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, ONEM is more volatile compared to SGFY. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs RCM Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, ONEM is priced at $16.47, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas RCM's P/E ratio is -102.21. In terms of profitability, ONEM's ROE is -0.24%, compared to RCM's ROE of -0.02%. Regarding short-term risk, ONEM is more volatile compared to RCM. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs BTSG Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, BTSG has a market cap of 4.1B. Regarding current trading prices, ONEM is priced at $16.47, while BTSG trades at $23.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas BTSG's P/E ratio is 87.67. In terms of profitability, ONEM's ROE is -0.24%, compared to BTSG's ROE of +0.03%. Regarding short-term risk, ONEM is more volatile compared to BTSG. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs BTSGU Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, BTSGU has a market cap of 4.1B. Regarding current trading prices, ONEM is priced at $16.47, while BTSGU trades at $82.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas BTSGU's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to BTSGU's ROE of +0.03%. Regarding short-term risk, ONEM is more volatile compared to BTSGU. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs PRVA Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, PRVA has a market cap of 2.8B. Regarding current trading prices, ONEM is priced at $16.47, while PRVA trades at $22.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas PRVA's P/E ratio is 191.42. In terms of profitability, ONEM's ROE is -0.24%, compared to PRVA's ROE of +0.02%. Regarding short-term risk, ONEM is more volatile compared to PRVA. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs WGS Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, WGS has a market cap of 2.1B. Regarding current trading prices, ONEM is priced at $16.47, while WGS trades at $72.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas WGS's P/E ratio is -52.38. In terms of profitability, ONEM's ROE is -0.24%, compared to WGS's ROE of -0.17%. Regarding short-term risk, ONEM is less volatile compared to WGS. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs PINC Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, PINC has a market cap of 1.9B. Regarding current trading prices, ONEM is priced at $16.47, while PINC trades at $23.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas PINC's P/E ratio is 22.61. In terms of profitability, ONEM's ROE is -0.24%, compared to PINC's ROE of +0.03%. Regarding short-term risk, ONEM is more volatile compared to PINC. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs PGNY Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, PGNY has a market cap of 1.9B. Regarding current trading prices, ONEM is priced at $16.47, while PGNY trades at $21.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas PGNY's P/E ratio is 38.56. In terms of profitability, ONEM's ROE is -0.24%, compared to PGNY's ROE of +0.12%. Regarding short-term risk, ONEM is less volatile compared to PGNY. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs CERT Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, CERT has a market cap of 1.9B. Regarding current trading prices, ONEM is priced at $16.47, while CERT trades at $11.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas CERT's P/E ratio is -573.25. In terms of profitability, ONEM's ROE is -0.24%, compared to CERT's ROE of -0.00%. Regarding short-term risk, ONEM is less volatile compared to CERT. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs SDGR Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SDGR has a market cap of 1.7B. Regarding current trading prices, ONEM is priced at $16.47, while SDGR trades at $22.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SDGR's P/E ratio is -8.71. In terms of profitability, ONEM's ROE is -0.24%, compared to SDGR's ROE of -0.45%. Regarding short-term risk, ONEM is less volatile compared to SDGR. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs NXGN Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, ONEM is priced at $16.47, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas NXGN's P/E ratio is -266.00. In terms of profitability, ONEM's ROE is -0.24%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, ONEM is more volatile compared to NXGN. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs PHR Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, PHR has a market cap of 1.5B. Regarding current trading prices, ONEM is priced at $16.47, while PHR trades at $25.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas PHR's P/E ratio is -34.84. In terms of profitability, ONEM's ROE is -0.24%, compared to PHR's ROE of -0.23%. Regarding short-term risk, ONEM is more volatile compared to PHR. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs OMCL Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, ONEM is priced at $16.47, while OMCL trades at $31.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas OMCL's P/E ratio is 67.43. In terms of profitability, ONEM's ROE is -0.24%, compared to OMCL's ROE of +0.02%. Regarding short-term risk, ONEM is more volatile compared to OMCL. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs GDRX Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, GDRX has a market cap of 1.4B. Regarding current trading prices, ONEM is priced at $16.47, while GDRX trades at $3.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas GDRX's P/E ratio is 56.14. In terms of profitability, ONEM's ROE is -0.24%, compared to GDRX's ROE of +0.07%. Regarding short-term risk, ONEM is less volatile compared to GDRX. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs AGTI Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, ONEM is priced at $16.47, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas AGTI's P/E ratio is -71.79. In terms of profitability, ONEM's ROE is -0.24%, compared to AGTI's ROE of -0.01%. Regarding short-term risk, ONEM is more volatile compared to AGTI. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs TDOC Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, ONEM is priced at $16.47, while TDOC trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas TDOC's P/E ratio is -1.19. In terms of profitability, ONEM's ROE is -0.24%, compared to TDOC's ROE of -0.68%. Regarding short-term risk, ONEM is less volatile compared to TDOC. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs TXG Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, TXG has a market cap of 1.1B. Regarding current trading prices, ONEM is priced at $16.47, while TXG trades at $9.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas TXG's P/E ratio is -7.01. In terms of profitability, ONEM's ROE is -0.24%, compared to TXG's ROE of -0.22%. Regarding short-term risk, ONEM is less volatile compared to TXG. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs EVH Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, EVH has a market cap of 1B. Regarding current trading prices, ONEM is priced at $16.47, while EVH trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas EVH's P/E ratio is -7.00. In terms of profitability, ONEM's ROE is -0.24%, compared to EVH's ROE of -0.11%. Regarding short-term risk, ONEM is less volatile compared to EVH. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs HSTM Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, HSTM has a market cap of 877M. Regarding current trading prices, ONEM is priced at $16.47, while HSTM trades at $28.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas HSTM's P/E ratio is 45.60. In terms of profitability, ONEM's ROE is -0.24%, compared to HSTM's ROE of +0.05%. Regarding short-term risk, ONEM is more volatile compared to HSTM. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs NUTX Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, NUTX has a market cap of 822.2M. Regarding current trading prices, ONEM is priced at $16.47, while NUTX trades at $148.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas NUTX's P/E ratio is 12.00. In terms of profitability, ONEM's ROE is -0.24%, compared to NUTX's ROE of +0.71%. Regarding short-term risk, ONEM is less volatile compared to NUTX. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs MPLN-WT Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, ONEM is priced at $16.47, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to MPLN-WT's ROE of -5.18%. Regarding short-term risk, ONEM is less volatile compared to MPLN-WT. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs CTEV Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, CTEV has a market cap of 618M. Regarding current trading prices, ONEM is priced at $16.47, while CTEV trades at $37.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas CTEV's P/E ratio is -0.52. In terms of profitability, ONEM's ROE is -0.24%, compared to CTEV's ROE of -5.18%. Regarding short-term risk, ONEM is less volatile compared to CTEV. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs ACCD Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, ONEM is priced at $16.47, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas ACCD's P/E ratio is -3.08. In terms of profitability, ONEM's ROE is -0.24%, compared to ACCD's ROE of -0.45%. Regarding short-term risk, ONEM is more volatile compared to ACCD. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs CCLDP Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, CCLDP has a market cap of 566.6M. Regarding current trading prices, ONEM is priced at $16.47, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas CCLDP's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to CCLDP's ROE of +0.21%. Regarding short-term risk, ONEM is more volatile compared to CCLDP. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs SLP Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SLP has a market cap of 563.9M. Regarding current trading prices, ONEM is priced at $16.47, while SLP trades at $28.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SLP's P/E ratio is 77.89. In terms of profitability, ONEM's ROE is -0.24%, compared to SLP's ROE of +0.04%. Regarding short-term risk, ONEM is less volatile compared to SLP. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs SHCR Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, ONEM is priced at $16.47, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SHCR's P/E ratio is -3.76. In terms of profitability, ONEM's ROE is -0.24%, compared to SHCR's ROE of -0.24%. Regarding short-term risk, ONEM is more volatile compared to SHCR. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs SLGC Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, ONEM is priced at $16.47, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SLGC's P/E ratio is -3.04. In terms of profitability, ONEM's ROE is -0.24%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, ONEM is less volatile compared to SLGC. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs SLGCW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, ONEM is priced at $16.47, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, ONEM's ROE is -0.24%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, ONEM is less volatile compared to SLGCW. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs MPLN Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, ONEM is priced at $16.47, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas MPLN's P/E ratio is -0.23. In terms of profitability, ONEM's ROE is -0.24%, compared to MPLN's ROE of -5.18%. Regarding short-term risk, ONEM is less volatile compared to MPLN. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs DH Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, DH has a market cap of 374.6M. Regarding current trading prices, ONEM is priced at $16.47, while DH trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas DH's P/E ratio is -0.79. In terms of profitability, ONEM's ROE is -0.24%, compared to DH's ROE of -1.07%. Regarding short-term risk, ONEM is less volatile compared to DH. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs TBRG Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, TBRG has a market cap of 357.7M. Regarding current trading prices, ONEM is priced at $16.47, while TBRG trades at $23.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas TBRG's P/E ratio is -19.52. In terms of profitability, ONEM's ROE is -0.24%, compared to TBRG's ROE of -0.10%. Regarding short-term risk, ONEM is more volatile compared to TBRG. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs SPOK Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SPOK has a market cap of 330.6M. Regarding current trading prices, ONEM is priced at $16.47, while SPOK trades at $16.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SPOK's P/E ratio is 20.87. In terms of profitability, ONEM's ROE is -0.24%, compared to SPOK's ROE of +0.10%. Regarding short-term risk, ONEM is more volatile compared to SPOK. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs NRC Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, NRC has a market cap of 321.7M. Regarding current trading prices, ONEM is priced at $16.47, while NRC trades at $14.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas NRC's P/E ratio is 13.84. In terms of profitability, ONEM's ROE is -0.24%, compared to NRC's ROE of +0.71%. Regarding short-term risk, ONEM is less volatile compared to NRC. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs TRHC Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, ONEM is priced at $16.47, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas TRHC's P/E ratio is -4.27. In terms of profitability, ONEM's ROE is -0.24%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, ONEM is more volatile compared to TRHC. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs HCAT Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, HCAT has a market cap of 281.2M. Regarding current trading prices, ONEM is priced at $16.47, while HCAT trades at $4.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas HCAT's P/E ratio is -3.51. In terms of profitability, ONEM's ROE is -0.24%, compared to HCAT's ROE of -0.20%. Regarding short-term risk, ONEM is less volatile compared to HCAT. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs SMFR Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, ONEM is priced at $16.47, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SMFR's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to SMFR's ROE of -0.17%. Regarding short-term risk, ONEM is less volatile compared to SMFR. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs OPRX Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, OPRX has a market cap of 244.5M. Regarding current trading prices, ONEM is priced at $16.47, while OPRX trades at $13.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas OPRX's P/E ratio is -15.74. In terms of profitability, ONEM's ROE is -0.24%, compared to OPRX's ROE of -0.13%. Regarding short-term risk, ONEM is less volatile compared to OPRX. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs SOPH Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SOPH has a market cap of 201.2M. Regarding current trading prices, ONEM is priced at $16.47, while SOPH trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SOPH's P/E ratio is -3.01. In terms of profitability, ONEM's ROE is -0.24%, compared to SOPH's ROE of -0.63%. Regarding short-term risk, ONEM is less volatile compared to SOPH. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs CPSI Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, ONEM is priced at $16.47, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas CPSI's P/E ratio is -183.80. In terms of profitability, ONEM's ROE is -0.24%, compared to CPSI's ROE of -0.18%. Regarding short-term risk, ONEM is less volatile compared to CPSI. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs EUDA Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, EUDA has a market cap of 123.4M. Regarding current trading prices, ONEM is priced at $16.47, while EUDA trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas EUDA's P/E ratio is -6.15. In terms of profitability, ONEM's ROE is -0.24%, compared to EUDA's ROE of +3.05%. Regarding short-term risk, ONEM is less volatile compared to EUDA. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs SY Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SY has a market cap of 117.2M. Regarding current trading prices, ONEM is priced at $16.47, while SY trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SY's P/E ratio is -1.11. In terms of profitability, ONEM's ROE is -0.24%, compared to SY's ROE of -0.26%. Regarding short-term risk, ONEM is less volatile compared to SY. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs AUGX Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, ONEM is priced at $16.47, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas AUGX's P/E ratio is -4.99. In terms of profitability, ONEM's ROE is -0.24%, compared to AUGX's ROE of -1.13%. Regarding short-term risk, ONEM is more volatile compared to AUGX. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs AMWL Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, AMWL has a market cap of 109.9M. Regarding current trading prices, ONEM is priced at $16.47, while AMWL trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas AMWL's P/E ratio is -0.69. In terms of profitability, ONEM's ROE is -0.24%, compared to AMWL's ROE of -0.48%. Regarding short-term risk, ONEM is less volatile compared to AMWL. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs CCLD Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, CCLD has a market cap of 91.8M. Regarding current trading prices, ONEM is priced at $16.47, while CCLD trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas CCLD's P/E ratio is -9.86. In terms of profitability, ONEM's ROE is -0.24%, compared to CCLD's ROE of +0.21%. Regarding short-term risk, ONEM is less volatile compared to CCLD. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs CCLDO Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, CCLDO has a market cap of 85.3M. Regarding current trading prices, ONEM is priced at $16.47, while CCLDO trades at $19.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas CCLDO's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to CCLDO's ROE of +0.21%. Regarding short-term risk, ONEM is more volatile compared to CCLDO. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs FORA Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, FORA has a market cap of 64.3M. Regarding current trading prices, ONEM is priced at $16.47, while FORA trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas FORA's P/E ratio is -17.17. In terms of profitability, ONEM's ROE is -0.24%, compared to FORA's ROE of -0.13%. Regarding short-term risk, ONEM is less volatile compared to FORA. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs BEAT Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, BEAT has a market cap of 60.9M. Regarding current trading prices, ONEM is priced at $16.47, while BEAT trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas BEAT's P/E ratio is -2.43. In terms of profitability, ONEM's ROE is -0.24%, compared to BEAT's ROE of -3.58%. Regarding short-term risk, ONEM is less volatile compared to BEAT. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs BEATW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, BEATW has a market cap of 48.5M. Regarding current trading prices, ONEM is priced at $16.47, while BEATW trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas BEATW's P/E ratio is -1.01. In terms of profitability, ONEM's ROE is -0.24%, compared to BEATW's ROE of -3.58%. Regarding short-term risk, ONEM is less volatile compared to BEATW. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs SNCE Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, ONEM is priced at $16.47, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SNCE's P/E ratio is -0.27. In terms of profitability, ONEM's ROE is -0.24%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, ONEM is more volatile compared to SNCE. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs AKLI Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, ONEM is priced at $16.47, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas AKLI's P/E ratio is -0.71. In terms of profitability, ONEM's ROE is -0.24%, compared to AKLI's ROE of -0.38%. Regarding short-term risk, ONEM is more volatile compared to AKLI. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs SHLT Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, ONEM is priced at $16.47, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SHLT's P/E ratio is -3.87. In terms of profitability, ONEM's ROE is -0.24%, compared to SHLT's ROE of -0.09%. Regarding short-term risk, ONEM is more volatile compared to SHLT. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs SHCRW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, ONEM is priced at $16.47, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, ONEM's ROE is -0.24%, compared to SHCRW's ROE of -0.24%. Regarding short-term risk, ONEM is less volatile compared to SHCRW. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs MGRX Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, MGRX has a market cap of 23.2M. Regarding current trading prices, ONEM is priced at $16.47, while MGRX trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas MGRX's P/E ratio is -0.45. In terms of profitability, ONEM's ROE is -0.24%, compared to MGRX's ROE of -0.73%. Regarding short-term risk, ONEM is less volatile compared to MGRX. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs RNLX Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, ONEM is priced at $16.47, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas RNLX's P/E ratio is -0.33. In terms of profitability, ONEM's ROE is -0.24%, compared to RNLX's ROE of +2.93%. Regarding short-term risk, ONEM is less volatile compared to RNLX. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs STRM Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, STRM has a market cap of 22.5M. Regarding current trading prices, ONEM is priced at $16.47, while STRM trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas STRM's P/E ratio is -2.05. In terms of profitability, ONEM's ROE is -0.24%, compared to STRM's ROE of -0.68%. Regarding short-term risk, ONEM is more volatile compared to STRM. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs LIFW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, ONEM is priced at $16.47, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas LIFW's P/E ratio is -0.02. In terms of profitability, ONEM's ROE is -0.24%, compared to LIFW's ROE of -3.08%. Regarding short-term risk, ONEM is more volatile compared to LIFW. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs VSEEW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, VSEEW has a market cap of 19.7M. Regarding current trading prices, ONEM is priced at $16.47, while VSEEW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas VSEEW's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to VSEEW's ROE of -6.10%. Regarding short-term risk, ONEM is more volatile compared to VSEEW. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs VSEE Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, VSEE has a market cap of 17.7M. Regarding current trading prices, ONEM is priced at $16.47, while VSEE trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas VSEE's P/E ratio is -11.30. In terms of profitability, ONEM's ROE is -0.24%, compared to VSEE's ROE of -6.10%. Regarding short-term risk, ONEM is less volatile compared to VSEE. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs BFRG Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, BFRG has a market cap of 16.1M. Regarding current trading prices, ONEM is priced at $16.47, while BFRG trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas BFRG's P/E ratio is -2.14. In terms of profitability, ONEM's ROE is -0.24%, compared to BFRG's ROE of -1.63%. Regarding short-term risk, ONEM is less volatile compared to BFRG. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs BBLN Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, ONEM is priced at $16.47, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas BBLN's P/E ratio is -0.04. In terms of profitability, ONEM's ROE is -0.24%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, ONEM is less volatile compared to BBLN. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs INOV Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, INOV has a market cap of 13.9M. Regarding current trading prices, ONEM is priced at $16.47, while INOV trades at $31.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas INOV's P/E ratio is 16.71. In terms of profitability, ONEM's ROE is -0.24%, compared to INOV's ROE of +0.03%. Regarding short-term risk, ONEM is more volatile compared to INOV. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs ONMD Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, ONMD has a market cap of 11.3M. Regarding current trading prices, ONEM is priced at $16.47, while ONMD trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas ONMD's P/E ratio is -1.09. In terms of profitability, ONEM's ROE is -0.24%, compared to ONMD's ROE of +0.60%. Regarding short-term risk, ONEM is less volatile compared to ONMD. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs SCNX Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SCNX has a market cap of 11.1M. Regarding current trading prices, ONEM is priced at $16.47, while SCNX trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SCNX's P/E ratio is 1.28. In terms of profitability, ONEM's ROE is -0.24%, compared to SCNX's ROE of +0.19%. Regarding short-term risk, ONEM is less volatile compared to SCNX. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs MSPR Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, MSPR has a market cap of 10.8M. Regarding current trading prices, ONEM is priced at $16.47, while MSPR trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas MSPR's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to MSPR's ROE of -3.08%. Regarding short-term risk, ONEM is less volatile compared to MSPR. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs ETAO Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, ONEM is priced at $16.47, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas ETAO's P/E ratio is -0.01. In terms of profitability, ONEM's ROE is -0.24%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, ONEM is less volatile compared to ETAO. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs HLTH Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, ONEM is priced at $16.47, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas HLTH's P/E ratio is -0.02. In terms of profitability, ONEM's ROE is -0.24%, compared to HLTH's ROE of -0.88%. Regarding short-term risk, ONEM is less volatile compared to HLTH. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs OTRK Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, OTRK has a market cap of 6.5M. Regarding current trading prices, ONEM is priced at $16.47, while OTRK trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas OTRK's P/E ratio is -0.09. In terms of profitability, ONEM's ROE is -0.24%, compared to OTRK's ROE of -1.76%. Regarding short-term risk, ONEM is more volatile compared to OTRK. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs ZCMD Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, ZCMD has a market cap of 5.8M. Regarding current trading prices, ONEM is priced at $16.47, while ZCMD trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas ZCMD's P/E ratio is -9.33. In terms of profitability, ONEM's ROE is -0.24%, compared to ZCMD's ROE of -0.03%. Regarding short-term risk, ONEM is less volatile compared to ZCMD. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs EUDAW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, EUDAW has a market cap of 5.4M. Regarding current trading prices, ONEM is priced at $16.47, while EUDAW trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas EUDAW's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to EUDAW's ROE of +3.05%. Regarding short-term risk, ONEM is more volatile compared to EUDAW. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs UPH Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, ONEM is priced at $16.47, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas UPH's P/E ratio is -0.07. In terms of profitability, ONEM's ROE is -0.24%, compared to UPH's ROE of -1.05%. Regarding short-term risk, ONEM is less volatile compared to UPH. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs PEARW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, ONEM is priced at $16.47, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas PEARW's P/E ratio is -0.00. In terms of profitability, ONEM's ROE is -0.24%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, ONEM is less volatile compared to PEARW. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs PEAR Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, ONEM is priced at $16.47, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas PEAR's P/E ratio is -0.08. In terms of profitability, ONEM's ROE is -0.24%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, ONEM is less volatile compared to PEAR. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs ACON Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, ACON has a market cap of 3.8M. Regarding current trading prices, ONEM is priced at $16.47, while ACON trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas ACON's P/E ratio is -0.56. In terms of profitability, ONEM's ROE is -0.24%, compared to ACON's ROE of -1.27%. Regarding short-term risk, ONEM is less volatile compared to ACON. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs HCTI Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, HCTI has a market cap of 3M. Regarding current trading prices, ONEM is priced at $16.47, while HCTI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas HCTI's P/E ratio is -0.01. In terms of profitability, ONEM's ROE is -0.24%, compared to HCTI's ROE of +2.95%. Regarding short-term risk, ONEM is less volatile compared to HCTI. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs FOXO Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, FOXO has a market cap of 2.7M. Regarding current trading prices, ONEM is priced at $16.47, while FOXO trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas FOXO's P/E ratio is -0.06. In terms of profitability, ONEM's ROE is -0.24%, compared to FOXO's ROE of -0.01%. Regarding short-term risk, ONEM is less volatile compared to FOXO. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs WGSWW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, WGSWW has a market cap of 2M. Regarding current trading prices, ONEM is priced at $16.47, while WGSWW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas WGSWW's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to WGSWW's ROE of -0.17%. Regarding short-term risk, ONEM is less volatile compared to WGSWW. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs WORX Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, WORX has a market cap of 1.8M. Regarding current trading prices, ONEM is priced at $16.47, while WORX trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas WORX's P/E ratio is -0.56. In terms of profitability, ONEM's ROE is -0.24%, compared to WORX's ROE of -0.32%. Regarding short-term risk, ONEM is less volatile compared to WORX. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs CMAX Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, ONEM is priced at $16.47, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas CMAX's P/E ratio is -0.00. In terms of profitability, ONEM's ROE is -0.24%, compared to CMAX's ROE of +30.94%. Regarding short-term risk, ONEM is less volatile compared to CMAX. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs ICCT Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, ICCT has a market cap of 1.3M. Regarding current trading prices, ONEM is priced at $16.47, while ICCT trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas ICCT's P/E ratio is -0.01. In terms of profitability, ONEM's ROE is -0.24%, compared to ICCT's ROE of -14.51%. Regarding short-term risk, ONEM is less volatile compared to ICCT. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs LIFWZ Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, ONEM is priced at $16.47, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to LIFWZ's ROE of -3.08%. Regarding short-term risk, ONEM is more volatile compared to LIFWZ. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs OTRKP Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, OTRKP has a market cap of 1M. Regarding current trading prices, ONEM is priced at $16.47, while OTRKP trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas OTRKP's P/E ratio is -0.08. In terms of profitability, ONEM's ROE is -0.24%, compared to OTRKP's ROE of -1.76%. Regarding short-term risk, ONEM is more volatile compared to OTRKP. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs KERNW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, ONEM is priced at $16.47, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas KERNW's P/E ratio is -0.00. In terms of profitability, ONEM's ROE is -0.24%, compared to KERNW's ROE of -2.22%. Regarding short-term risk, ONEM is less volatile compared to KERNW. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs KERN Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, ONEM is priced at $16.47, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas KERN's P/E ratio is -0.01. In terms of profitability, ONEM's ROE is -0.24%, compared to KERN's ROE of -2.22%. Regarding short-term risk, ONEM is less volatile compared to KERN. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs MSPRZ Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, MSPRZ has a market cap of 72K. Regarding current trading prices, ONEM is priced at $16.47, while MSPRZ trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to MSPRZ's ROE of -3.08%. Regarding short-term risk, ONEM is more volatile compared to MSPRZ. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs LIFWW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, ONEM is priced at $16.47, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas LIFWW's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to LIFWW's ROE of -3.08%. Regarding short-term risk, ONEM is more volatile compared to LIFWW. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs CMAXW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, ONEM is priced at $16.47, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas CMAXW's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to CMAXW's ROE of +30.94%. Regarding short-term risk, ONEM is more volatile compared to CMAXW. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs ACONW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, ACONW has a market cap of 17.6K. Regarding current trading prices, ONEM is priced at $16.47, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas ACONW's P/E ratio is -0.01. In terms of profitability, ONEM's ROE is -0.24%, compared to ACONW's ROE of -1.27%. Regarding short-term risk, ONEM is less volatile compared to ACONW. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs MSPRW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, MSPRW has a market cap of 5.9K. Regarding current trading prices, ONEM is priced at $16.47, while MSPRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas MSPRW's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to MSPRW's ROE of -3.08%. Regarding short-term risk, ONEM is more volatile compared to MSPRW. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs UTRS Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, UTRS has a market cap of 888. Regarding current trading prices, ONEM is priced at $16.47, while UTRS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas UTRS's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to UTRS's ROE of -1.11%. Regarding short-term risk, ONEM is more volatile compared to UTRS. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs CERN Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, CERN has a market cap of 0. Regarding current trading prices, ONEM is priced at $16.47, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas CERN's P/E ratio is 55.84. In terms of profitability, ONEM's ROE is -0.24%, compared to CERN's ROE of +0.14%. Regarding short-term risk, ONEM is more volatile compared to CERN. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs MTBCO Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, ONEM is priced at $16.47, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas MTBCO's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to MTBCO's ROE of +0.21%. Regarding short-term risk, ONEM is more volatile compared to MTBCO. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs NH Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, NH has a market cap of 0. Regarding current trading prices, ONEM is priced at $16.47, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas NH's P/E ratio is -0.12. In terms of profitability, ONEM's ROE is -0.24%, compared to NH's ROE of +0.35%. Regarding short-term risk, ONEM is less volatile compared to NH. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.
ONEM vs CHNGU Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, ONEM is priced at $16.47, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas CHNGU's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, ONEM is more volatile compared to CHNGU. This indicates potentially higher risk in terms of short-term price fluctuations for ONEM.
ONEM vs SMFRW Comparison
ONEM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ONEM stands at 3.4B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, ONEM is priced at $16.47, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ONEM currently has a P/E ratio of -7.77, whereas SMFRW's P/E ratio is N/A. In terms of profitability, ONEM's ROE is -0.24%, compared to SMFRW's ROE of -0.17%. Regarding short-term risk, ONEM is less volatile compared to SMFRW. This indicates potentially lower risk in terms of short-term price fluctuations for ONEM.